jeffreybrowen posted: " By BY PAM BELLUCK, SHEILA KAPLAN AND REBECCA ROBBINS Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen's Aduhelm, or aducanumab. Published: July 19, 2021 at 10:12PM "
|
Subscribe to:
Post Comments (Atom)
-
Arooj Fatima posted: " Indian IT professionals can now enjoy Germany's one of the best offers in terms of immigration. ...
-
trentbartlett posted: "Rumours around this snack's return have been floating around the internet for a little while now...

No comments:
Post a Comment